About me

I am an independent expert in the field of RNAi Therapeutics with an emphasis on science and business development strategy.

Trained in RNAi molecular biology at the universities of Edinburgh (BSc Hons 2000-2002), Oxford (DPhil 2002-2005), and Stanford (post-doctoral research), I have lived and breathed RNA(i) Therapeutics development for the last 18 years.

A scientist at heart, it is my strong belief that sound science is the basis for any successful value creation and investments related to RNA(i) Therapeutics drug development.

In addition to my science background, I have been an avid investor in the stock markets since 1995 with a focus on biotechnology in general and the RNA Therapeutics sector in particular.

You can contact me by writing to: my first name DOT my last name AT gmail DOT com.
By Dirk Haussecker. All rights reserved.

Disclaimer: This blog is not intended for distribution to or use by any person or entity who is a citizen or resident of, or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would subject the author or any of his collaborators and contributors to any registration or licensing requirement within such jurisdiction. This blog expresses only my opinions, they may be flawed and are for entertainment purposes only. Opinions expressed are a direct result of information which may or may not be accurate, and I do not assume any responsibility for material errors or to provide updates should circumstances change. Opinions expressed in this blog may have been disseminated before to others. This blog should not be taken as investment, legal or tax advice. The investments referred to herein may not be suitable for you. Investments particularly in the field of RNAi Therapeutics and biotechnology carry a high risk of total loss. You, the reader must make your own investment decisions in consultation with your professional advisors in light of your specific circumstances. I reserve the right to buy, sell, or short any security including those that may or may not be discussed on my blog.